Laboratory centrifuges have long been the quiet workhorses of scientific research — separating blood, isolating proteins, and prepping samples for everything from routine diagnostics to cutting-edge genomic studies. According to Grand View Research, the global laboratory centrifuges market was valued at USD 1.73 billion in 2023 and is projected to climb to USD 2.54 billion by 2030, expanding at a CAGR of 5.70% during the 2024–2030 forecast period. That steady growth trajectory reflects a market shaped by technological innovation, rising healthcare demands, and shifting regional dynamics.

Core Market Drivers & Innovations

Several forces are converging to push this market forward.

Personalized medicine and genomics. As diagnostics move toward more individualized treatment approaches, demand for precise sample separation has grown. Centrifuges play a foundational role in genomics and proteomics workflows, and manufacturers are racing to keep pace with more sophisticated research needs.

Chronic disease burden. Rising rates of cancer, diabetes, and cardiovascular disease are driving up diagnostic testing volumes worldwide. Projections cited in the report suggest cancer cases could climb dramatically by mid-century, while cardiovascular disease deaths are expected to rise sharply through 2050. Since these conditions typically require extensive lab-based monitoring, the ripple effect on centrifuge demand is significant.

Product innovation. Manufacturers are investing heavily in smarter, more efficient equipment. Notable recent launches include:

• Beckman Coulter's Allegra V-15R Benchtop Centrifuge, offering multiple rotor configurations and programmable runs
• Eppendorf's Centrifuge 5910 Ri, featuring a touchscreen interface and tiered user-management security
• Eppendorf's Centrifuge 5427 R, notable for using a low-impact cooling agent to reduce environmental footprint
• Haier Biomedical's benchtop high-speed refrigerated centrifuge series with built-in rotor balancing and vibration monitoring

Digital integration. Centrifuges are increasingly designed to sync with laboratory information management systems (LIMS), streamlining data handling and boosting lab productivity.

R&D investment. Government and private-sector funding is fueling growth too — India's PRIP scheme for pharmaceutical and medtech innovation, for instance, includes a budget outlay of nearly USD 600 million, underscoring the scale of public investment flowing into life sciences infrastructure.

Ready to see the full picture? Download a free sample of the Laboratory Centrifuges Market report to explore detailed segmentation, forecasts, and regional data.

Regional Leadership

North America led the market in 2023, capturing a 35.10% revenue share. This dominance stems from a strong base of established manufacturers, heavy R&D spending in biotech and pharma, and steady product innovation — Thermo Fisher's DynaSpin single-use centrifuge system is one example of the kind of advanced equipment coming out of the region. Within North America, the U.S. stands out, partly driven by an uptick in tuberculosis cases requiring specialized sample processing, alongside robust clinical trial activity.

Europe continues to see solid growth, underpinned by strong research funding and rising chronic disease rates, along with ongoing improvements in centrifuge design and throughput.

Asia Pacific is the fastest-growing region. Strategic partnerships and market expansion — such as DKSH's 2023 distribution agreement with Hettich for Australia and New Zealand — are helping global players establish deeper footholds across the region.

Latin America and the Middle East & Africa are also poised for meaningful growth, driven by expanding lab infrastructure, rising chronic disease burdens (including a significant tuberculosis burden in countries like Brazil), and growing clinical trial and R&D activity.

Key Industry Competitors

The competitive landscape is crowded but well-defined, with a mix of established instrumentation giants and specialized players. Leading companies include:

• Andreas Hettich GmbH & Co. KG
• Danaher Corporation (Beckman Coulter, Inc.)
• Eppendorf SE
• Thermo Fisher Scientific Inc.
• HERMLE Labortechnik GmbH
• KUBOTA Corporation
• Sartorius AG
• Sigma Laborzentrifugen GmbH
• QIAGEN
• Cardinal Health

These companies are competing through new product launches, acquisitions, and regional expansion. Recent moves include Hettich Group's growth partnership with Bregal Unternehmerkapital to expand into Asia and the U.S., its acquisition of Kirsch Medical to bolster its cooling and freezing solutions, and Boekel Scientific's 2023 launch of a diversified centrifuge product line spanning general purpose, STAT, economy, and blood bank applications.

Looking Ahead

With the equipment segment already commanding over 82% of market share and floor-standing centrifuges leading by model type, the fundamentals of this market remain stable even as innovation accelerates at the edges — particularly in benchtop models, accessories, and diagnostics-focused applications. As chronic disease diagnostics, genomics research, and clinical trial volumes continue to climb globally, laboratory centrifuges are set to remain indispensable infrastructure across healthcare and life sciences.

Need data tailored to your business? Customize this report with your specific regions, segments, or focus areas — free customization is available with purchase.